About 1 in 10 prescription drugs — mainly brand-name and expensive drugs and those for rare diseases — has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...

In her final thoughts regarding gastroesophageal cancer, Laura Bobolts, PharmD, BCOP, overviews patient support services and programs. Laura Bobolts, PharmD, BCOP: It’s an exciting time in the ...

The vast majority of drugmakers are either considering or have already established direct-to-patient (DTP) programs, cutting out middlemen to offer services like virtual care consultations, payment ...

While digital technologies have reshaped many industries, healthcare is one of the last to rely on faxes and phone calls. This holds true for workflows in physician offices and hospitals, which are ...

While much attention has been given to the novel science behind cell and gene therapies (CGTs), the success of every precision medicine starts and ends with the patient. The novel science behind CGTs ...

Greater transparency and independent evaluation are needed to understand the impact of the patient support programs that pharmaceutical companies offer for many expensive drugs, according to ...